Definitive Contract 140D0426C0011
Award Date 2/26/26
Potential Completion Date 3/1/27
Potential Value $594K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Worth, TX 76107, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a $249,726.25 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Memsel Inc., a small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of an "Advanced Hydrogel-Based Drug Delivery System for Enhanced Neuroprotection in Traumatic Brain Injuries" and has a period of performance through May 6, 2025. The contract was set aside for small businesses.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command (MEDCOM) to Memsel Inc., a self-certified small disadvantaged business. The $249,918.26 contract is for the development of a multi-component hydrogel containing stabilized, encapsulated bacteriophages for the treatment of drug-resistant bacterial infections. This SBIR Phase I contract was set aside for small businesses and is part of MEDCOM's broader efforts to identify...
- GT Biosciences, Inc. has been awarded a $599,992 firm fixed-price contract by the National Institutes of Health under the Small Business Innovation Research (SBIR) Program, Topic 5, focused on precision brain targeting through non-invasive delivery mechanisms. The contract, designated as a total small business set-aside, was awarded on March 2, 2026, with an ultimate completion date of March 1, 2028. The awardee will perform work at its facility in Cambridge, Massachusetts. The SBIR Program...
- This is a $1,063,367.96 firm fixed price contract awarded by the Defense Health Agency (DHA) to Mign Inc., a self-certified small disadvantaged business, woman-owned small business, and manufacturer of goods. The contract was awarded under the SBIR (Small Business Innovation Research) program, specifically Phase II, and is titled "REVOLUTIONIZING RECOVERY INNOVATIONS IN DIGITAL DESIGN AND RAPID MANUFACTURING MEDICAL R AND D." The contract has a total small business set-aside...
- <p>This is a firm-fixed-price Definitive Contract awarded by the Department of the Army Medical Command to Neuralstem, Inc., a for-profit organization, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, valued at $149,975.71, is for research and development efforts related to the SBIR Program Phase I Action. The contract was set aside for total small business and has a completion date of December 6, 2018.</p>
- This federal contract award, valued at $86,055.00, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Plexon, Inc., a for-profit technology company based in Dallas, Texas. The contract is for the procurement of a Neural Data Acquisition System, which will support advanced biomedical research programs. The contract has a period of performance from August 2, 2019, to August 1, 2020, and was designated as a total small...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $21,450 firm fixed-price purchase order to Medical Research Support LLC, a women-owned small business based in North Potomac, Maryland, for clinical research support services. The contract, which runs from February 6, 2026 through February 5, 2027, supports a Phase 1/Phase 2 open-label trial evaluating LMP744, a novel indenoisoquinolone c-Myc/topoisomerase 1 inhibitor, in patients with recurrent glioblastoma. This...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Lifesensors Inc., doing business as Gene Transcription TECH. The contract is for applied/exploratory biomedical research, with a ceiling value of $149,550 and a period of performance through March 30, 2010. Lifesensors is a biotechnology company that conducts research on novel therapeutic approaches such as targeted...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $225,000.00 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Mattek Corp, a for-profit manufacturer of human tissue models and assay kits. The contract is for the development of electrospun biodegradable membrane inserts, to be performed from July 27, 2020 to April 26, 2021. Mattek previously supported federal biomedical research...
- This federal contract award is for a $299,999 Small Business Innovation Research (SBIR) Phase 1 contract issued by the National Institute of Mental Health (NIMH), which is part of the National Institutes of Health (NIH). The contract was awarded to Vitruvian Bio, LLC, a small, woman-owned, and disadvantaged business, to develop point-of-care assays for measuring HIV viral load and drug adherence. This contract is part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR...